AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ALAD | Aminolevulinate dehydratase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDOA | Aldolase A, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
AMPD1 | Adenosine monophosphate deaminase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMPD3 | Adenosine monophosphate deaminase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AMT | Aminomethyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ANGPTL3 | Angiopoietin-like 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Mixed |
ANK3 | Ankyrin 3, node of Ranvier (ankyrin G) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
ANKRD11 | Ankyrin repeat domain 11 | Disease related genes
| | | | | Expressed in all |
ANXA5 | Annexin A5 | Disease related genes Plasma proteins
| | | | | Expressed in all |
AP1S1 | Adaptor-related protein complex 1, sigma 1 subunit | Disease related genes Plasma proteins
| | | | | Expressed in all |
AP1S2 | Adaptor-related protein complex 1, sigma 2 subunit | Disease related genes
| | | | | Expressed in all |
AP5Z1 | Adaptor-related protein complex 5, zeta 1 subunit | Disease related genes
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
APPL2 | Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 | Disease related genes
| | | | | Expressed in all |
APTX | Aprataxin | Disease related genes
| | | | | Expressed in all |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | | | | Expressed in all |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARSA | Arylsulfatase A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |